According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
Is this cannabis-based alternative to opioid painkillers the key to treating chronic pain? - It’s high time for a ...
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...
Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...
The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
It is a potential non-opioid therapy for chronic pain. Latigo develops non-opioid pain medications that directly target the source of pain. Its mission is to offer rapid-acting pain relief without ...
Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results